21 years...
a timeline of achievements

 

 

June 1998

June 1998

$50 million project receives government and philanthropic backing

IMB is officially given the green light following funding commitments from the State and Federal Governments, UQ and a transformational gift from the Atlantic Philanthropies.

Read more

 

March 1999

March 1999

Winning design announced for bioscience precinct

The winning design is announced for the Queensland Bioscience Precinct, a joint UQ-CSIRO project with a gross floor area of 35,000 square metres, the same floor space as many 30+-storey office blocks.

Read more

 

January 2000

January 2000

The birth of an institute

Two previous centres – the Centre for Molecular and Cellular Biology and the Drug Design and Development Centre are officially merged to become the Institute for Molecular Bioscience.

 

21 May 2003

21 May 2003

Queensland research powerhouse unveiled

Queensland Bioscience Precinct is officially launched as the largest research facility in Australia, bringing together 700 scientists from IMB and CSIRO.

Read more

The IMB team outside the Institute at UQ St Lucia.
The IMB team outside the Institute at UQ St Lucia.
 

May 2004

May 2004

Scientists discover what could be the instruction manual of life

IMB scientists uncover a new class of genetic elements that could radically alter our notion of how the genome ‘comes to life’ to form humans.

Read more

 

November 2005

November 2005

Breaking new ground in fight against infection and chronic disease

IMB researchers make a vital discovery about how immune cells orchestrate their response to disease-causing microbes.

Read more

Microscopic view of macrophages.
Microscopic view of macrophages.
 

April 2009

April 2009

International team cracks mammalian gene control code

IMB researchers are part of a major worldwide effort understanding how genes are controlled and discovering the tiniest genetic element yet known.

Read more

DNA is a long molecule that contains our unique genetic code.
DNA is a long molecule that contains our unique genetic code.
 

October 2012

October 2012

Unmasking the deadly secrets of pancreatic cancer

The underlying mutations responsible for pancreatic tumours in more than 100 patients is published – IMB’s contribution to the International Cancer Genome Consortium, a worldwide effort to sequence the genomes of 25,000 tumours from 50 different types of cancer.

Read more

 

April 2013

April 2013

Algae to fuel a renewable future

A solar biofuels pilot plant to develop microalgae as a source of clean energy was opened at Pinjarra Hills in Brisbane.

Read more

The solar biofuels plant at Pinjarra Hills.
The solar biofuels plant at Pinjarra Hills.
 

May 2013

May 2013

Mystery disease solved by gene experts

A global team led by IMB researchers discovered a previously-unknown disease caused by a gene never before associated with human disease, providing answers for families of children around the world without a diagnosis.

Read more

 

December 2013

December 2013

Researchers grow kidney from stem cells

IMB researchers announce they have grown a mini-kidney using stem cells, a breakthrough that paves the way for improved treatments for patients with kidney disease.

Read more

Kidney cells.
Kidney cells.
 

March 2014

March 2014

Developing an oral pain reliever from snail venom

A protein found in cone snail venom is the basis for new substances that could lead to the development of safe and effective oral medications for the treatment of chronic nerve pain.

Read more

Researchers are exploring cone snail venom for new treatments.
Researchers are exploring cone snail venom for new treatments.
 

July 2014

July 2014

Mutations identified in global fight against cancer

IMB researchers lead a team identifying the major underlying mutations in pancreatic and ovarian cancers as part of the International Cancer Genome Consortium.

Read more

 

November 2014

November 2014

Genetic test unlocks cause of Brisbane boy’s rare disease

Queensland researchers lead an international effort to uncover the gene behind a young Brisbane boy’s rare developmental condition, which only seven people in the world have been diagnosed with.

Read more

 

February 2015

February 2015

New molecule could improve treatments for inflammatory diseases

A small molecule that blocks a key driver of inflammatory diseases is developed by IMB, UQ and Irish scientists.

Read more

 

March 2015

March 2015

Spider venom may have legs as future painkiller

Seven molecules in spider venom are found that block the pathway that sends pain signals from nerves to the brain, a discovery that could inspire new painkillers.

Read more

Potential painkillers have been found in spider venom.
Potential painkillers have been found in spider venom.
 

June 2015

June 2015

Worldwide hunt for next antibiotic

A global search to ‘crowdsource’ antibiotics capable of combating superbugs is launched.

Read more

Superbugs are bacteria with resistance to all currently used antibiotics.
Superbugs are bacteria with resistance to all currently used antibiotics.
 

July 2015

July 2015

IMB spin-out raises $40 million to advance drug to clinical trial

Protagonist Therapeutics raises $40 million to begin clinical trials of an oral drug for Inflammatory Bowel Disease.

Read more

 

March 2016

March 2016

Worldwide carbon dioxide emissions could rise more rapidly than expected

CO2 emissions could rise more quickly than expected, locking the world into more rapid global warming, IMB researchers team with other Queensland researchers to discover.

Read more

 

March 2017

March 2017

Fatal spider venom could protect against post-stroke brain damage

Researchers discover that a small protein from the venom of an Australian funnel-web spider could protect the brain from stroke-induced injury.

Read more

Researchers are exploring spider venoms for new treatments.
Researchers are exploring spider venoms for new treatments.
 

August 2017

August 2017

Potential treatment for brain cancer as drug shrinks tumours

A drug previously approved to treat breast cancer could also shrink a common form of childhood brain tumour, IMB and international researchers discover.

Read more

 

September 2017

September 2017

Finding new risk factors for motor neurone disease

An international team finds new genetic risk factors associated with motor neurone disease.

Read more

 

January 2018

January 2018

‘Forgotten’ antibiotic offers hope against worst superbugs

‘Forgotten’ antibiotics are taken off the shelf and re-engineered to develop new drugs to combat some of the world’s most dangerous superbugs.

Read more

 

February 2018

February 2018

Scientists discover off-switch for ‘molecular machine’ active in many diseases

Researchers discover how an inflammation process automatically switches off in healthy cells, a discovery that could be the key to stopping damage caused by uncontrolled inflammation in a range of diseases.

Read more

The inflammasome is the molecular machine at the heart of inflammation.
The inflammasome is the molecular machine at the heart of inflammation.
 

March 2018

March 2018

Unlocking the genetic combinations that control complex diseases

Researchers develop a method to pinpoint genes linked to 12 complex diseases, including Crohn’s disease, rheumatoid arthritis, and coronary heart disease.

Read more

 

March 2018

March 2018

Turning plants into medicine factories

Australian researchers take a step closer to turning plants into medicine factories through producing key molecules in a range of plants that do not naturally produce them, but are suitable for large-scale production of pharmaceuticals.

Read more

 

September 2018

March 2018

Fatal spider venom could protect against post-stroke brain damage

IMB researchers discover a peptide in the venom of funnel-web spiders that could drastically reduce brain damage following stroke.

Read more

 

November 2018

March 2018

Start-up raises $63M to develop drugs for inflammatory diseases

Inflazome, a biotech company developing new drugs to block harmful inflammation, secured a further investment of $63 million. The intellectual property is based on work by researchers from UQ’s Institute for Molecular Bioscience (IMB) and Trinity College Dublin.

Read more

 

March 2019

March 2018

Harnessing zinc could help us develop non-antibiotic UTI treatments

IMB researchers continued to discover more about our immune system in the effort to find alternatives to the use of antibiotics  - investigating zinc in the fight against bacterial infections. 

Read more

 

September 2020

March 2018

$600M deal for inflammation start-up

The start-up company Inflazome, which develops treatments for inflammatory diseases, was acquired in a landmark deal by the Swiss multinational pharmaceutical company Roche. The company was based on a research partnership between The University of Queensland and Trinity College Dublin (TCD) and targets inflammasomes, which are understood to drive many chronic inflammatory conditions.

Read more

 

March 2021

March 2018

Backyard scientists key to new antibiotics

IMB launches ‘Soils for Science’ - a citizen science project aiming to unearth new antibiotics in backyards, gardens and farms across Queensland.

Read more

 

July 2021

March 2018

Repairing hearts with deadly spider venom

A peptide found by IMB researchers in the venom of funnel-web spiders,  was found to prevent damage caused by a heart attack and extend the life of donor hearts used for organ transplants.

Read more